Researchers Discover New Breast Cancer Culprit
When scientists identify concentrations of regulatory T cells (immune-system cells) in breast cancer tumors, it usually signifies an unfavorable prognosis. Now researchers have uncovered why.
Resveratrol and Rapamycin: A Power Couple
Resveratrol, a compound found in red wine, may have a tumor-suppressing effect on breast cancer cells when combined with rapamycin, an immunosuppressant drug.
Fooled by Folic Acid?
According to a new study working with rat animal models, female offspring of rats who took folic acid supplements before conception, during pregnancy and while breast-feeding have twice the rate of breast cancer.
3-D Trend in Movies Goes Scientific
The FDA today approved the Selenia Dimensions System, the first X-ray mammography device that provides three-dimensional (3-D) images of the breast for breast cancer screening and diagnosis.
Learning from History
In recognition of Black History Month we're taking a look at diseases for which African-Americans are at higher risk -- and what to do about them.
Breast Cancer Surgery May Become Less Invasive
A new study finds that removing underarm lymph nodes in women with early breast cancer (and who also undergo a lumpectomy) may not be necessary, thus saving them considerable pain and complications.
Aggressive Form of Breast Cancer Linked to Gene Mutation
A new study from Tufts University School of Medicine finds why individuals who inherit a particular family of mutations have a higher risk of developing a very aggressive form of breast cancer.
Illegal Drugs Aren't the Only Kind That Kill
Avastin®, a cancer drug, has been shown to increase patient death from adverse events when used in conjunction with chemotherapy or biological therapy, according to new analysis of previous studies.
Down but Not Out
Breast cancer survivors may be prone to hip fractures once they hit middle age, according to a study from Northwestern University Feinberg School of Medicine.
Earlier Hormone Replacement Therapy Linked to Breast Cancer
Women who start hormone replacement therapy (HRT) as menopause begins have a higher risk of breast cancer than women who begin the therapy later, according to a new study.